Telix Pharmaceuticals Ltd. (TLX)

9.53 +0.27 (+2.92%) USD  |  NASDAQ  |  Oct 29, 10:05
More

Telix Pharmaceuticals Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for TLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Expenses (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
March 31, 2024 --

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Mesoblast Ltd. --
Immutep Ltd. --
CSL Ltd. --
Ceryvyn Therapeutics Ltd. --
Propanc Biopharma, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade